Vanda Surges After FDA Approval
May 07, 2009 at 13:19 PM EDT
Shares of Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) soared nearly tenfold by leaping $7.04 to $8.12 after the FDA approved its schizophrenia drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.